Proud to expand our work with @AstraZeneca into inflammatory bowel disease. IBD affects 10M+ people worldwide, with many still cycling through treatments. With Immunai’s IDE™ and AMICA™, we’re uncovering and exploring new immune targets. @FierceBiotech: https://t.co/ISS72FQdcL
Immunai’s Grand Collaboration is now open!
Single-cell immune sequencing for academic researchers to advance immune system understanding.
✔️ High-resolution, multi-omic data
🧬 Enrichment of the AMICA atlas
🗓️ Applications due by Oct 1, 2025
#scRNAseq#Immunai#AcademicResearch
Honored to be named Immunology Innovation of the Year by the @BioTech_Awards! Our commitment to advancing immunology with AI can help pharma teams understand immune responses like never before. https://t.co/374iaiwKu6
We’re teaming up with @TevaUSA to bring precision to clinical trials in immunology & immuno-oncology. Using AMICA™ & IDE™, we’re improving trial decision-making by refining drug mechanisms, dose selection, and biomarker insights. More in @BiopharmaTrend https://t.co/htKwAnS0Nz
I am very excited to be part of this.
@Immunaitech are partnering with AstraZeneca to leverage AI to advance clinical trials and gain key insights into drug discovery.
Proud to enter a multi-year partnership with AstraZeneca to optimize clinical trials in oncology. Using our AI-powered platforms, we’re working together to bring new therapies to patients faster and more efficiently. https://t.co/VocZSNPvYK
@nyckevil@notSoJunkDNA (asking as a Westchester County resident, who sometimes is asked: how is it there in "Upstate NY" 😀)
And yeah, we also felt it here in Westchester.
Personal Thoughts:
(not for everyone, feel free to skip)
For the longest time, I struggled with my identity.
A Palestinian kid born inside Israel. Like…wtf.
Many of my friends refuse to this day to say the word “Israel” and call themselves “Palestinian” only.
But since I was 12, that did not make sense to me.
So I decided to mix the two and become a “Palestinian-Israeli”
I thought this term reflected who I was.
Palestinian first. Israeli second.
But after recent events, I started to think.
And think.
And think.
And then my thoughts turned to anger.
I realized that if Israel were to be “invaded” like that again, we would not be safe. To a terrorist invading Israel, all citizens are targets.
900 Israelis died so far. More than 40 of them are Arabs. Killed by other Arabs. And even 2 Thai people died too.
And I do not want to live under a Palestinian government.
Which means I only have one home, even if I’m not Jewish:
Israel.
That’s where all my family lives. That’s where I grew up. That’s the country I want to see continue to exist so I can exist.
Palestine should exist too as an independent state. And I hope to see the country thrive and become less extreme and more prosperous. I love Palestine and have invested in Palestine.
But it’s not my home.
So from today forward,
I view myself as an “Israeli-Palestinian”.
Israeli first.
Palestinian second.
Sometimes it takes a shock like this to see so clearly.
Hi Twitterverse, I have opportunities for one or two graduate students to work on human host-microbe interaction. Please help re-tweet this to get to interested parties, or have them contact me. Thank you! 🙏😁
If you are seeing the enrichment of a particular taxon in your disease model, first check if it has a bunker downstairs. If it does, assume that its enrichment in disease may have nothing to do with the emergence or progress of the disease, and disprove that first.
Delighted to announce the publication of this work from my PhD! We show that metabolically independent microbes associated with human gut “dysbiosis” may not in fact be causal of disease, but instead selected for under stressful conditions. (1/4)
https://t.co/fPa4tq9ZGi
@CarolineGlick לא להסכים עם המכתב שכתבנו זה בסדר, אבל למה לשקר?
רוב הבוגרים שאינם בשירות קבע חתמו על המכתב.
הבוגרים שעדיין בשירות קבע לא הוזמנו לחתום על המכתב מטעמים ברורים.